What is CBG?
CBG, or cannabigerol, is the latest cannabinoid (other than CBD and THC) to attract attention. CBG and CBD are thought to have many similarities—they both interact with the endocannabinoid system and are thought to have a multitude of benefits. But CBG is is more abundant in young plants, where CBD is prevalent in adult hemp.
Adult hemp plants consist of only about 1 percent CBG as opposed to around 20 percent CBD. It’s the main reason CBG isn’t as widely known or as readily abundant as CBD.
How does it work?
CBG is referred to as “the mother cannabinoid” because it births all other cannabinoids. All cannabinoids start as CBGa before they break down into THCa, CBDa, CBCa. Eventually, these acidic forms turn into THC, CBD, CBC, etc., when exposed to heat or ultraviolet light.
CBG and CBD have slightly different molecular structures that may result in different behavior. A major difference in CBD vs CBG boils down to the amount of research at our disposal. From the available studies, we know that CBG offers potential uses that slightly differ from CBD, such as treating Inflammatory Bowel Disease and glaucoma.
Why use CBG?
CBG produces effects that are exclusive to the way it works in the body. It interacts with receptors inside and outside of the endocannabinoid system to create effects that THC and CBD aren’t capable of.
The mother cannabinoid also appears to aid in relaxing the muscles. By stopping the reuptake of GABA, a relaxing neurotransmitter, CBG may help to relieve tension and tightness.
A 2015 study found CBG protects neurons in mice with Huntington’s disease, a nerve cell degeneration brain disorder.
CBG inhibited growth of colorectal cancer cells in mice as well. According to this study, CBG slowed down tumors and chemically-induced colon carcinogenesis.
In a study that looked at the effects of five different cannabinoids on bladder contractions, CBG tested best at inhibiting muscle shrinking, so it may be a future tool in preventing bladder dysfunction disorders.